691 related articles for article (PubMed ID: 27976797)
1. Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model.
Buszman PP; Michalak MJ; Pruski M; Fernandez C; Jelonek M; Janas A; Savard C; Gwiazdowska-Nowotka B; Żurakowski A; Wojakowski W; Buszman PE; Milewski K
Cardiol J; 2016; 23(6):657-666. PubMed ID: 27976797
[TBL] [Abstract][Full Text] [Related]
2. Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries.
Sperling C; Waliszewski MW; Kherad B; Krackhardt F
Ther Adv Cardiovasc Dis; 2019; 13():1753944719826335. PubMed ID: 30803407
[TBL] [Abstract][Full Text] [Related]
3. Randomised comparison of vascular response to biodegradable polymer sirolimus eluting and permanent polymer everolimus eluting stents: An optical coherence tomography study.
Koppara T; Tada T; Xhepa E; Kufner S; Byrne RA; Ibrahim T; Laugwitz KL; Kastrati A; Joner M
Int J Cardiol; 2018 May; 258():42-49. PubMed ID: 29544956
[TBL] [Abstract][Full Text] [Related]
4. Vascular response to bioresorbable polymer sirolimus-eluting stent vs. permanent polymer everolimus-eluting stent at 9-month follow-up: an optical coherence tomography sub-study from the CENTURY II trial.
Kuramitsu S; Kazuno Y; Sonoda S; Domei T; Jinnouchi H; Yamaji K; Soga Y; Shirai S; Ando K; Saito S
Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):34-40. PubMed ID: 26333375
[TBL] [Abstract][Full Text] [Related]
5. Comparison of long-term in-stent vascular response between abluminal groove-filled biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent: 3-year OCT follow-up from the TARGET I trial.
Xu B; Zhang YJ; Sun ZW; Qiao SB; Chen SL; Zhang RY; Pan DR; Pang S; Zhang Q; Xu L; Yang YJ; Leon MB; Gao RL
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1489-96. PubMed ID: 26208685
[TBL] [Abstract][Full Text] [Related]
6. Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV Trial.
Teeuwen K; van der Schaaf RJ; Adriaenssens T; Koolen JJ; Smits PC; Henriques JP; Vermeersch PH; Tjon Joe Gin RM; Schölzel BE; Kelder JC; Tijssen JG; Agostoni P; Suttorp MJ
JACC Cardiovasc Interv; 2017 Jan; 10(2):133-143. PubMed ID: 28104206
[TBL] [Abstract][Full Text] [Related]
7. Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography.
Tada T; Byrne RA; Schuster T; Cuni R; Kitabata H; Tiroch K; Dirninger A; Gratze F; Kaspar K; Zenker G; Joner M; Schömig A; Kastrati A
Cardiovasc Revasc Med; 2013; 14(2):84-9. PubMed ID: 23352095
[TBL] [Abstract][Full Text] [Related]
8. Comparison of neointimal coverage and extra-stent lumen between sirolimus and everolimus-eluting stent using optical coherence tomography.
Oda T; Okamura T; Yamada J; Miyagi N; Uehara H; Nao T; Tateishi H; Maeda T; Nakamura T; Shiraishi K; Nakashima T; Nishimura S; Miura T; Matsuzaki M; Yano M
Heart Vessels; 2016 Apr; 31(4):449-56. PubMed ID: 25614415
[TBL] [Abstract][Full Text] [Related]
9. Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms.
Buszman PP; Milewski K; Pająk J; Jelonek M; Orlik B; Krauze A; Gwiazdowska-Nowotka B; Wojakowski W; Tellez A; Granada JF; Buszman PE
EuroIntervention; 2014 Oct; 10(6):724-31. PubMed ID: 24469344
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent vascular response following delivery of sirolimus via fast releasing, biodegradable polymer stent matrix: an experimental study in the porcine coronary model of restenosis.
Buszman PP; Orlik B; Pająk J; Jelonek M; Krauze A; Janas A; Legutko J; Wojakowski W; Buszman PE; Milewski K
Kardiol Pol; 2015; 73(10):916-23. PubMed ID: 25985728
[TBL] [Abstract][Full Text] [Related]
11. Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography.
Fujino Y; Attizzani GF; Tahara S; Naganuma T; Takagi K; Yabushita H; Wang W; Tanaka K; Matsumoto T; Kawamoto H; Yamada Y; Amano S; Watanabe Y; Warisawa T; Sato T; Mitomo S; Kurita N; Ishiguro H; Hozawa K; Tsukahara T; Motosuke M; Bezerra HG; Nakamura S; Nakamura S
Int J Cardiol; 2017 Mar; 230():284-292. PubMed ID: 28065691
[TBL] [Abstract][Full Text] [Related]
12. Comparison of sirolimus eluting stent with bioresorbable polymer to everolimus eluting stent with permanent polymer in bifurcation lesions: Results from CENTURY II trial.
Orvin K; Carrie D; Richardt G; Desmet W; Assali A; Werner G; Ikari Y; Fujii K; Goicolea J; Dangoisse V; Manari A; Saito S; Wijns W; Kornowski R
Catheter Cardiovasc Interv; 2016 May; 87(6):1092-100. PubMed ID: 26268482
[TBL] [Abstract][Full Text] [Related]
13. Very early neointimal coverage of new biodegradable polymer drug-eluting stent compared with durable polymer everolimus-eluting stent evaluated by optical frequency domain imaging.
Kobayashi N; Ito Y; Yamawaki M; Araki M; Sakai T; Sakamoto Y; Mori S; Tsutsumi M; Nauchi M; Honda Y; Tokuda T; Makino K; Shirai S; Hirano K
Int J Cardiovasc Imaging; 2018 Apr; 34(4):515-522. PubMed ID: 29159531
[TBL] [Abstract][Full Text] [Related]
14. Comparisons of early vascular reactions in biodegradable and durable polymer-based drug-eluting stents in the porcine coronary artery.
Ijichi T; Nakazawa G; Torii S; Nagamatsu H; Yoshikawa A; Souba J; Isobe A; Hagiwara H; Ikari Y
PLoS One; 2019; 14(1):e0209841. PubMed ID: 30629613
[TBL] [Abstract][Full Text] [Related]
15. Serial Evaluation of Vascular Response After Implantation of a New Sirolimus-Eluting Stent With Bioabsorbable Polymer (MISTENT): an optical coherence tomography and histopathological study.
Attizzani GF; Bezerra HG; Chamié D; Fujino Y; Spognardi AM; Stanley JR; Yamamoto H; Mehanna E; Wang W; Carlyle WC; McClain JB; Costa MA
J Invasive Cardiol; 2012 Nov; 24(11):560-8. PubMed ID: 23117309
[TBL] [Abstract][Full Text] [Related]
16. First-in-man randomised comparison of the Angiolite durable fluoroacrylate polymer-based sirolimus-eluting stent versus a durable fluoropolymer-based everolimus-eluting stent in patients with coronary artery disease: the ANGIOLITE trial.
Moreu J; Moreno-Gómez R; Pérez de Prado A; García Del Blanco B; Trillo R; Pinar E; Molina E; Zueco J; Merchán A; Díaz-Fernández JF; Amat I
EuroIntervention; 2019 Dec; 15(12):e1081-e1089. PubMed ID: 31310239
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
Toledano Delgado FJ; Alvarez-Ossorio MP; de Lezo Cruz-Conde JS; Bellido FM; Romero Moreno MÁ; Fernández-Aceytuno AM; de Lezo Herrerosde Tejada JS; Pineda SO; Saint-Gerons JM; Pavlovic D
Catheter Cardiovasc Interv; 2014 Nov; 84(5):720-6. PubMed ID: 24174291
[TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography findings: insights from the "randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions" (PRISON IV) trial.
Teeuwen K; Spoormans EM; Bennett J; Dubois C; Desmet W; Ughi GJ; Belmans A; Kelder JC; Tijssen JGP; Agostoni P; Suttorp MJ; Adriaenssens T
EuroIntervention; 2017 Aug; 13(5):e522-e530. PubMed ID: 28512069
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the performance of zotarolimus- and everolimus-eluting stents by optical coherence tomography and coronary angioscopy.
Masawa T; Abe S; Toyoda S; Sakuma M; Nasuno T; Kageyama M; Tokura M; Koizumi S; Taguchi I; Inoue T
Heart Vessels; 2016 Aug; 31(8):1230-8. PubMed ID: 26271923
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety and efficacy of second-generation everolimus-eluting stents compared to other limus-eluting stents and bare metal stents in patients with acute coronary syndrome.
Omar A; Torguson R; Kitabata H; Pendyala LK; Loh JP; Magalhaes MA; Satler LF; Suddath WO; Pichard AD; Waksman R
Catheter Cardiovasc Interv; 2014 Dec; 84(7):1053-60. PubMed ID: 24619969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
